1Liu PP, Mason JW. Advances in the understanding of myocarditis[J].Circulation, 2001,104(9):1076-1082.
2Cihakova D, Rose NR. Pathogenesis of myocarditis anddilated cardiomyopathy [J]. Adv Immunol, 2008, 99: 95- 114.
3Cooper LT, Baughman KL, Feldman AM, et al.The role of endomyocardial biopsy in the management of cardio- vascular disease: a scientific statement from the Ameri-can Heart Association, the American College of Cardio- logy, and the European Society of Cardiology. Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology [J]. J Am Coil Cardiol, 2007, 50(19): 1914-1931.
5Rose NR. The adjuvant effect in infection and autoimmu- nity[J]. Clin Rev Allergy Immunol, 2008, 34(3): 279-282.
6Chen P, Chen R, Yang Y, et al. Coxsackievirus B3 infection promotes generation of myeloid dendritic cells from bone marrow and accumulation in the myoeardium [J]. Int Immunopharmaeol, 2009,9(11):1304-1312.
4Bochmann MF, Kopf M, Mansland BJ, et al. Chemokines: more than just road signs[J]. Nat Rev Immunol, 2006, 6 (2) : 159- 164.
5Kivisakk P, trebst C, Eekstein DJ, et al. Chemokine-based therapies for MS: how do we get there from here? [J]. Trends Immunology, 2001, 22(11):591-593.
6Gu L, Tseng S, Homer RM, et al. Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1[J].Nature, 2000, 404(6776):407-411.
7Corrigall VM, Arastu M, khan S, et al. Functional IL2 receptor beta (CD122) and gamma (CD132) chains are expressed by fibroblast-like synovioeytes: activation by IL2 stimulates monocyte chemoattraetant protein-1 production[J]. J Immuno, 2001, 166(6):4141-4147.
8Chiu BC, Shang X, Frait KA, et al. Differential effects of ageing on cytokine and chemokine responses during type-1 (mycobacterial) and type-2 (schistosomal) pulmonary granulomatous inflammation in mice[J]. Mech Ageing Dev, 2002, 123 (4) : 313- 326.
9Jones BW, Heldwein KA, Means TK, et al. Differential roles of Toll-like receptors in the elicitation of proinflammatory responses by macrophages[J]. Ann Rheum Dis, 2001,60 Suppl 3:6-12.
10[1]Tam PE.Coxsackievirus myocarditis:interplay between virus and host in the pathogenesis of heart disease.Viral Immunol,2006,19(2):133-46.
7Luo H, Wong J, Wong B. Protein degradation systems in viral myocarditis leading to dilated cardiomyopathy. Cardiovascu- lar Research ,2010,85 ( 2 ) : 347 - 356.
8Olimulder MA, Van Es J, Galjee MA. The importance of car- diac MRI as a diagnostic tool in viral myocarditis - induced cardiomyopathy. Netherlands Heart Journal, 2009,17 ( 12 ) : 481 - 486.
9Blauwet LA, Cooper LT. Antimierobial agents for myocarditis : target the pathway, not the pathogen. Heart, 2010,96 (7) :494-495.
10Schultz JC, Hilliard AA, Cooper LT, et al. Diagnosis and Treatment of Viral Myocarditis. Mayo Clin Proc, 2009,84( 11 ) :1001 - 1009.
